Hbk Investments L P Uni Qure N.V. Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $575,053 - $1.44 Million	-20,995 Reduced 38.31%	33,801 $2.02 Million
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $348,748 - $518,993	15,296 Added 38.72%	54,796 $1.58 Million
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $1.18 Million - $1.7 Million	39,500 New	39,500 $1.44 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.